HIGHLIGHTS
- who: Kathrin Endt et al. from the Germany, University of Zu00fcrich, Dekanat Vetsuisse-Fakultu00e4t Immunology have published the research work: A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection, in the Journal: (JOURNAL)
- how: All cells were acquired using a digital flow cytometer (LSR II BD Biosciences) and data were analyzed with FlowJo software (Tree Star). The authors used mice lacking CD8 T_cells due to missing a constituent of major histocompatibility class I molecules (b2M -/- 21 22) or mice unable to produce RSV-specific . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.